HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Abstract
Gastric cancer is the second leading cause of cancer mortality in the world and its management, especially in advanced stages, has evolved relatively little. In particular, no targeted modality has so far been incorporated to its treatment armamentarium. HER2 overexpression is increasingly recognized as a frequent molecular abnormality, driven as in breast cancer by gene amplification. There is mounting evidence of the role of HER2...
Paper Details
Title
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Published Date
Sep 1, 2008
Journal
Volume
19
Issue
9
Pages
1523 - 1529
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History